Archives for August 2020

August 2020 - Page 8 of 12 - Money Morning - Only the News You Can Profit From

How to Play the “Long Game” with the Top Gold ETF to Buy Now

by

It's not just major news media that's talking about gold right now. Even social media is abuzz with plenty of talk and reviews about the yellow metal.

"'Gold is going higher' despite recent surge, says investor who's managed a precious-metals fund for a quarter-century"

"Stock market bulls should consider owning gold as an insurance policy"

"Gold's Run to Continue"

That's why today I want to talk about three of the best gold options for what I call playing the "long game" in gold. They can let you capture some nice profits in the long term. Because this gold story isn't over – as I'll show you… Full Story

That's why today I want to talk about three of the best gold options for what I call playing the "long game" in gold. They can let you capture some nice profits in the long term. Because this gold story isn't over - as I'll show you...

Why Uber, Lyft, and Other Gig Economy Stocks Are Down Now

by

On Monday, a California judge ruled that Uber Technologies Inc.

(NYSE: UBER) and Lyft Inc.

(NASDAQ: LYFT) must classify their drivers as employees (as opposed to independent contractors) in a stunning preliminary injunction.

Both stocks dropped about 2% on the news.

The ruling means these companies would have to provide their drivers traditional benefits like health insurance, workers compensation, and more.

These additional benefits would become very big expenses to the already unprofitable businesses.

Lyft lost $2.6 billion in fiscal 2019.

Uber lost $8.5 billion.

And neither appear to be close to profitability so far this year…

Read more...

10 Best Investment Apps That Aren’t Robinhood

by

Swarms of new investors jumped into the market in the first quarter of 2020.

Mobile investment apps grew their new accounts by as much as 170%.

Whether you're a new or experienced investor, there's probably a platform for you.

Robinhood is among the best.

But there could be one or two with tools better suited for where you are in your investing career.

Let's look at some of the best investment apps that aren't Robinhood.

Read more...

Make This Robinhood Options Trade Now for 130% Profit Potential

by

There's a better way to play some of the most exciting innovations than buying growth stocks.

And that's buying options on those growth stocks.

When an investment straddles the line between tech and a must-have industry like healthcare, it makes Money Morning Quantitative Specialist Chris Johnson's mouth water.

Today, he's found a company poised to deliver outsized profits in these two explosive areas.

Read more...

Profit on This Biotech-Enabler That’s Suddenly a “Buy”

by

"Lead, follow, or get out of the way."

This is one of those well-known aphorisms that's been around forever – though its originator is unknown.

Truth be told, it doesn't matter who said it first. It's a great bit of advice.

Especially as we interpret it.

In our investment work here at Money Morning, we always seek to lead Wall Street and the rest of the packrat investment crowd.

We never follow, especially since "the crowd" tends to be indecisive, late to the gun – or flat out wrong.

And we always get out of the way – sidestepping the dust-rising thump that's an inevitable result of the miscues and sins of the Wall Street Goliath.

It's a simple formula. And a successful one.

And it's the reason we keep outperforming "the crowd."

Like the 2,067% gain on biotech Galapagos NV, the very first stock I recommended on the very first day I published my Member-based service, Private Briefing, back in August 2011.

My readers also pulled down peak gains of more than 2,892% in Nvidia, 2,828% in Advanced Micro Devices, 818% in biotech buyout Pharmacyclics, and more.

Today, I've decided to share my latest insight on one of my big biotech winners with Money Morning readers because the opportunity is too good to keep to ourselves. And since my colleague Michael Robinson recently talked about 2020's record-crushing biotech IPOs, it's the perfect time to share this.

The company I'm showing you today is essential to biotech stocks. It's a "biotech-enabler" that's zoomed 1,755% since I first told my readers about it back in June 2013.

In 2013, it was trading at $8.14.

It closed July 30 at $151.25 – not long after Investor's Business Daily said the stock had entered a "Buy Zone."

True, but where were they seven years and 1,755% ago?

Of course, what's important now is what comes next – and it's clear this stock's run isn't over… Full Story

Best Penny Stock Now for 222% Potential

by

The healthcare system has been overwhelmed by the COVID-19 pandemic this year.

But that doesn't mean the greater healthcare industry is failing.

In fact, healthcare is going to vastly expand over the next few years.

And the particular healthcare sector we're covering today is expected to grow 242% by 2024.

Read more...

3 Best High-Yield Dividend Stocks to Buy Today

by

Finding reliable high-yield dividend stocks has been harder than ever since the start of the coronavirus pandemic.

To help you add income to your portfolio at a time when it seems nearly impossible, I've researched the companies that best fit this criteria.

That means zeroing in on a must-have industries, searching corporate balance sheets to find solid companies, and looking for insider buying.

That's given me three of the best high-yield stocks you can be comfortable adding to your portfolio right now…

Read more...

Dow Jones Now Up After Latest Trump Order

by

The Dow Jones now is ticking up as Congress debates the latest executive order by President Donald Trump.

The order would extend unemployment benefits, delay tax payments, and temporarily suspend student loan payments.

More on what's moving the Dow today, below….

Read more...